Merit Medical Systems (MMSI) vs Pulse Biosciences (PLSE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulse Biosciences (PLSE) has outperformed Merit Medical Systems (MMSI) over the past year, gaining 147.1% versus a gain of 2.9%. Over five years, PLSE leads with a +126.7% price change compared with +22.3% for MMSI. Merit Medical Systems is the larger company by market cap ($5.09 billion vs $3.56 billion), about 1.4 times the size.
Merit Medical Systems converts more of its revenue into profit, with a net margin of 8.5% versus -20794.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MMSI | PLSE |
|---|---|---|
| Share price | $85.25 | $49.98 |
| Market cap | $5.09B | $3.56B |
| 1-day change | +0.19% | +1.81% |
| YTD return | -3.46% | +257.54% |
| 1-year return | +2.89% | +147.06% |
| 5-year return | +22.27% | +126.74% |
| P/E ratio (TTM) | 35.08 | — |
| Forward P/E | 18.49 | — |
| EPS (TTM) | $2.43 | $-1.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.52B | $350.00K |
| Revenue growth (YoY) | +11.75% | — |
| Net income (latest FY) | $128.49M | $-72.78M |
| Gross margin | 48.70% | -54.00% |
| Operating margin | 12.19% | -21982.57% |
| Net margin | 8.48% | -20794.57% |
| 52-week high | $94.75 | $58.90 |
| 52-week low | $59.74 | $12.56 |
| Distance from 52-week high | -10.03% | -15.14% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +19.00% | +13.05% |
| Average volume | 795.56K | 506.50K |
| Shares outstanding | 59.71M | 71.32M |
| Employees | 7,500 | 116 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLSE has outperformed MMSI by 144.2 percentage points over the past year.
- Merit Medical Systems is more profitable, keeping 8.5 cents of every revenue dollar as net income versus -20794.6 cents for Pulse Biosciences.
About Merit Medical Systems
MMSI stock →Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Health Care · Medical/Dental Instruments · 7,500 employees
About Pulse Biosciences
PLSE stock →Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Health Care · Medical/Dental Instruments · 116 employees
MMSI vs PLSE FAQ
Which is bigger, Merit Medical Systems or Pulse Biosciences?
Merit Medical Systems (MMSI) is larger, with a market capitalization of $5.09B compared with $3.56B for Pulse Biosciences (PLSE).
Which stock has performed better over the past year, MMSI or PLSE?
PLSE returned +147.06% over the past 12 months, compared with +2.89% for MMSI (price return, excluding dividends). Past performance does not predict future results.
Are Merit Medical Systems and Pulse Biosciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.